Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (9267)	3/18/1999 4:37:00 PM
From: Bluegreen	Read Replies (2) \| Respond to of 17367

George, if sweeping changes aren't made soon the FDA is going to be the laughing stock of the world. Why would ANYONE think the FDA is better at efficacy than safety? We have witnessed their whimsical efficacy standards, now their safety record is in shambles! Leave efficacy deciding issues to off label means and concentrate on SAFETY! Just recently DURACT, REDUX and now this. >>>>>>>Drug Rezulin linked to about 28 deaths - company WASHINGTON (Reuters) - Drug maker Warner-Lambert Co. said Thursday its diabetes pill Rezulin had been linked to about 28 deaths. Company spokeswoman Carol Goodrich also said the drug had been associated with about seven liver transplants. A Food and Drug Administration panel is scheduled to review the safety of Rezulin at a meeting next Friday. Goodrich said both the company and FDA officials agreed on those figures after reviewing reports of serious side effects associated with Rezulin. ''Our number and the FDA's number is approximately 35 deaths and transplants,'' Goodrich said in a telephone interview. Rezulin is used to treat adult-onset diabetes, and Warner-Lambert believes the drug's benefits to diabetics outweigh the risks, Goodrich said. Last July, after 14 people taking the drug died, the company changed the drug's label and advised doctors to conduct regular liver tests of patients taking the drug. 15:52 03-18-99<<<<<<